Cargando…
[(18)F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes
BACKGROUND: At present there is no consensus on irradiation treatment volumes for intermediate to high-risk primary cancers or recurrent disease. Conventional imaging modalities, such as CT, MRI and transrectal ultrasound, are considered suboptimal for treatment decisions. Choline-PET/CT might be co...
Autores principales: | Würschmidt, Florian, Petersen, Cordula, Wahl, Andreas, Dahle, Jörg, Kretschmer, Matthias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095991/ https://www.ncbi.nlm.nih.gov/pubmed/21529377 http://dx.doi.org/10.1186/1748-717X-6-44 |
Ejemplares similares
-
Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
por: Clauser, Paola, et al.
Publicado: (2023) -
(18)F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study
por: Pizzuto, Daniele Antonio, et al.
Publicado: (2022) -
(18)F-FDG PET–CT Diagnosis of Tuberculosis in Celiac Lymph Nodes
por: Mao, Xi Bao, et al.
Publicado: (2020) -
Reirradiation of recurrent breast cancer with and without concurrent chemotherapy
por: Würschmidt, Florian, et al.
Publicado: (2008) -
Spectrum of [(18)F]FDG-PET/CT Findings in Benign Lymph Node Pathology
por: Zeman, Merissa N., et al.
Publicado: (2021)